1. ICER says AbbVie’s Rinvoq for RA may be cost-effective but still questions the value of JAK class — Gilead, Galapagos share 52-week update on filgotinib — UPS gets clearance to expand medical drone delivery service across US — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Melinta

Discussion in 'Biotech Startups' started by anonymous, Aug 1, 2017 at 11:54 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Nice try, RBB - repackaged garbage still stinks.
     
  2. anonymous

    anonymous Guest

    Jeannie Lloyds is running the show here. This place is doomed. She is a black cloud and ruins every company she works for.
     
  3. anonymous

    anonymous Guest

    She is the worst!
     
  4. anonymous

    anonymous Guest

    They had national teleconference. First thing was bankruptcy is an option. They quickly retracted and said last option although interestingly it was first thing said! Complete shit show from the start here.